TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9850427

Group type: EXPERIMENTAL
Intervention: New amitriptyline tablet formulation (amitriptylin 25 von ct)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Reference preparation (28.3 mg amitriptyline hydrochloride)
Number of subjects: 18
Study: 7853069

Group type: EXPERIMENTAL
Intervention: Physician intervention providing educational demonstration of anxiety and reporting system for summarizing anxiety symptom levels and functioning status.
Number of subjects: 573

Group type: COMPARATOR
Intervention: Control arm (physicians not receiving the intervention).
Number of subjects: 573
Study: 2679853

Group type: EXPERIMENTAL
Intervention: High dose metoclopramide with dexamethasone and lorazepam
Number of subjects: 81

Group type: COMPARATOR
Intervention: Dexamethasone and lorazepam
Number of subjects: 81

Group type: COMPARATOR
Intervention: Oral dexamethasone alone
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Dexamethasone and metoclopramide
Number of subjects: 81
Study: 31562827

Group type: EXPERIMENTAL
Intervention: 0.5% RSFP
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: 2.5% RSFP
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: 12.5% RSFP
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: RSFP-supplemented diets
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: RSFP-supplemented diet
Number of subjects: 216
Study: 30311085

Group type: EXPERIMENTAL
Intervention: 0.1 mg/mL TBO
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Diode laser (633 nm, 20 mW, 6 J/cm2)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Combination of TBO and diode laser
Number of subjects: 56

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 56
Study: 29097293

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) using everolimus‐eluting stents
Number of subjects: 1788

Group type: COMPARATOR
Intervention: Coronary artery bypass graft (CABG)
Number of subjects: 1788

Group type: EXPERIMENTAL
Intervention: Both PCI and CABG
Number of subjects: 1788
Study: 26438556

Group type: EXPERIMENTAL
Intervention: Laser acupuncture (LA) at the Yintang point, 0.3 J of energy applied for 30 seconds, 2 minutes before heel lancing.
Number of subjects: 42

Group type: COMPARATOR
Intervention: Oral sucrose, 0.5 mL of 24% sucrose administered orally via syringe, 2 minutes before heel lancing.
Number of subjects: 42
Study: 23750463

Group type: EXPERIMENTAL
Intervention: Interpersonally focused therapy-cognitive behavioral analysis system of psychotherapy (CBASP)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Time-matched health and wellness control (HW)
Number of subjects: 248
Study: 21242864

Group type: EXPERIMENTAL
Intervention: Unilateral balloon kyphoplasty
Number of subjects: 49

Group type: COMPARATOR
Intervention: Bilateral balloon kyphoplasty
Number of subjects: 49
Study: 20329605

Group type: EXPERIMENTAL
Intervention: Modified Sanmiao Powder (SMP)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 94
Study: 17094160

Group type: EXPERIMENTAL
Intervention: Partners' anxiety
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Perceptions of relationship quality from women with breast cancer and their partners
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Women's anxiety
Number of subjects: 96
Study: 15240608

Group type: EXPERIMENTAL
Intervention: Testosterone replacement (Sustanon 100)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 12195057

Group type: EXPERIMENTAL
Intervention: Carbon fiber intervertebral fusion cage
Number of subjects: 103

Group type: COMPARATOR
Intervention: Cloward procedure
Number of subjects: 103
Study: 9615264

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 7915773

Group type: EXPERIMENTAL
Intervention: IVIgG 0.8 g/kg once
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: IVIgG 1 g/kg on 2 consecutive days
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Intravenous anti-D 25 micrograms/kg on 2 consecutive days
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Oral prednisone 4 mg/kg per day with tapering and discontinuation by day 21
Number of subjects: 146
Study: 2583258

Group type: EXPERIMENTAL
Intervention: Intermittent melphalan and prednisone (MP)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 5-drug combination MOCCA
Number of subjects: 110
Study: 1103552

Group type: EXPERIMENTAL
Intervention: Dipropylacetate (D.P.A.)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31307503

Group type: EXPERIMENTAL
Intervention: Nifurtimox (NFX) 480 mg/day for 120 days
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Benznidazole (BZN) 300 mg/day for 60 days followed by placebo for 60 days
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Benznidazole (BZN) 150 mg/day for 120 days
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Nifurtimox (NFX) 240 mg/day for 120 days
Number of subjects: 300
Study: 28608165

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Ticagrelor and Clopidogrel
Number of subjects: 4000
Study: 26243374

Group type: EXPERIMENTAL
Intervention: Caffeine (400 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 22905856

Group type: EXPERIMENTAL
Intervention: Dolutegravir (DTG) 50 mg once daily
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Dolutegravir (DTG) 50 mg twice daily
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 20843402

Group type: EXPERIMENTAL
Intervention: Group-based home-collaborative dietary education (HCDE) programme, 12 sessions of group counselling
Number of subjects: 474

Group type: COMPARATOR
Intervention: Control group (conventional school classroom education)
Number of subjects: 474
Study: 18053050

Group type: EXPERIMENTAL
Intervention: Dysport (5 U)
Number of subjects: 18

Group type: COMPARATOR
Intervention: BOTOX (2 U)
Number of subjects: 18
Study: 17429150

Group type: EXPERIMENTAL
Intervention: Health centres with co-financing model (n=107)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Health centres without co-financing model (n=31)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Health centres with co-financing model
Number of subjects: 138
Study: 15037702

Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 0
Study: 12791022

Group type: EXPERIMENTAL
Intervention: One-step procedure (Group I)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Two-step procedure (Group II)
Number of subjects: 26
Study: 9243563

Group type: EXPERIMENTAL
Intervention: Self-reports of heroin use at intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-reports of cocaine use at intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-reports of heroin use at posttreatment followup
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-reports of cocaine use at posttreatment followup
Number of subjects: 0
Study: 8515544

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MPS) 15 mg.kg‐1 i.v. 60 minutes after CPB
Number of subjects: 40

Group type: COMPARATOR
Intervention: No Methylprednisolone (MPS) administration
Number of subjects: 40
Study: 2835788

Group type: EXPERIMENTAL
Intervention: Topical LTB4 (100-900 ng applied once a week for up to 7 weeks depending on lesion type)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Vehicle (50% ethanol)
Number of subjects: 36
Study: 28941259

Group type: EXPERIMENTAL
Intervention: Aripiprazole (1–15 mg/day)
Number of subjects: 86
Study: 26754832

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 1255

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1255
Study: 24239295

Group type: EXPERIMENTAL
Intervention: Oral probiotic capsules for 7 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo for 7 days
Number of subjects: 60
Study: 23731968

Group type: EXPERIMENTAL
Intervention: Nomogram arm (ANH used for predicted probability of transfusion ≥ 50%)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Clinical arm (ANH used for resection of ≥ 3 liver segments)
Number of subjects: 114
Study: 20673626

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus carboplatin (PC)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Topotecan plus carboplatin and paclitaxel (TPC)
Number of subjects: 326
Study: 19517661

Group type: EXPERIMENTAL
Intervention: 10 mL of 0.5% bupivacaine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 10 mL of 0.5% bupivacaine with 0.5 mg neostigmine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no local infiltration)
Number of subjects: 90
Study: 15925049

Group type: EXPERIMENTAL
Intervention: Cetrorelix (GnRH antagonist)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Busereline (GnRH agonist)
Number of subjects: 131
Study: 12860551

Group type: EXPERIMENTAL
Intervention: Bone mineral density measurement in symptomatic athletes
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Bone mineral density measurement after recovery from symptoms
Number of subjects: 14

Group type: COMPARATOR
Intervention: Bone mineral density measurement in nonathlete control subjects
Number of subjects: 14

Group type: COMPARATOR
Intervention: Bone mineral density measurement in healthy athletes
Number of subjects: 14
Study: 10828925

Group type: EXPERIMENTAL
Intervention: Educational pamphlet
Number of subjects: 486

Group type: COMPARATOR
Intervention: Control group (no pamphlet)
Number of subjects: 486
Study: 9259041

Group type: EXPERIMENTAL
Intervention: Relaxation training with a clinical psychologist
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study: 8456894

Group type: EXPERIMENTAL
Intervention: Indomethacin (50 mg)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Terbutaline (5 mg)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 3757442

Group type: EXPERIMENTAL
Intervention: Atropine (13 individuals)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Propranolol (10 individuals)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Dynamic exercise without blockade
Number of subjects: 23
Study: 30246241

Group type: EXPERIMENTAL
Intervention: Patient Navigation intervention
Number of subjects: 3754

Group type: COMPARATOR
Intervention: No barriers reported
Number of subjects: 3754
Study: 27181566

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 3641

Group type: COMPARATOR
Intervention: Heparin plus GPI
Number of subjects: 3641
Study: 24798870

Group type: EXPERIMENTAL
Intervention: 250 mg JNJ-41443532
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: 1000 mg JNJ-41443532
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: 30 mg pioglitazone
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 22695756

Group type: EXPERIMENTAL
Intervention: Sublingual nicotine tablets (SNT)
Number of subjects: 250
Study: 20484175

Group type: EXPERIMENTAL
Intervention: β-carotene (20 mg per day)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 18548397

Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 1497

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1497
Study: 15645186

Group type: EXPERIMENTAL
Intervention: Oral tramadol 50 mg (drops) followed by tramadol sustained release 100 mg orally, placebo rectally
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Rectal tramadol 100 mg, placebo orally
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral tramadol
Number of subjects: 60
Study: 11922358

Group type: EXPERIMENTAL
Intervention: Internal Fixation (IF)
Number of subjects: 409

Group type: COMPARATOR
Intervention: Arthroplasty
Number of subjects: 409
Study: 9659818

Group type: EXPERIMENTAL
Intervention: Elderly patients with dementia (hip fracture, hemiplegia, hemiparesis, senile dementia of Alzheimer type, multi-infarct dementia)
Number of subjects: 696

Group type: COMPARATOR
Intervention: Osteoarthropathy patients with normal intelligence
Number of subjects: 696
Study: 7626318

Group type: EXPERIMENTAL
Intervention: Bed rest (4 months)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Reambulation (5-6 weeks after bed rest)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Reambulation
Number of subjects: 8
Study: 3382169

Group type: EXPERIMENTAL
Intervention: Plasmapheresis
Number of subjects: 245

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 245
Study: 31742316

Group type: EXPERIMENTAL
Intervention: Olive oil (20 mL)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: C8-dietary oil (2-OG + MCFAs)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tricaprylin (MCFAs; negative control)
Number of subjects: 20

Group type: COMPARATOR
Intervention: C8-dietary oil vs Tricaprylin
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: GIP response
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Distal enteroendocrine responses
Number of subjects: 20
Study: 30597280

Group type: EXPERIMENTAL
Intervention: Immersive VR surgical simulator training
Number of subjects: 16

Group type: COMPARATOR
Intervention: Traditional introductory teaching session (non-VR group)
Number of subjects: 16
Study: 28089528

Group type: EXPERIMENTAL
Intervention: Hydrogel spacer (SpaceOAR system) implantation
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Hydrogel spacer infiltration into the rectal wall
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Asymmetrical hydrogel spacer placement
Number of subjects: 149
Study: 26071975

Group type: EXPERIMENTAL
Intervention: β-blocker therapy
Number of subjects: 2553

Group type: COMPARATOR
Intervention: Control (no β-blocker therapy)
Number of subjects: 2553
Study: 23592849

Group type: EXPERIMENTAL
Intervention: Strategies for Teaching based on Autism Research
Number of subjects: 119

Group type: COMPARATOR
Intervention: Structured Teaching
Number of subjects: 119
Study: 21917762

Group type: EXPERIMENTAL
Intervention: Divalproex sodium
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 19853690

Group type: EXPERIMENTAL
Intervention: High-intensity interval exercise training (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 40
Study: 16696743

Group type: EXPERIMENTAL
Intervention: Therapeutic CPAP
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham CPAP
Number of subjects: 39
Study: 14980926

Group type: EXPERIMENTAL
Intervention: PCEA (ropivacaine 3.2 mg plus fentanyl 8 microg/dose) with DM 90 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: IV-PCA (morphine 2 mg/dose) with DM 90 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: PCEA (ropivacaine 3.2 mg plus fentanyl 8 microg/dose) with placebo
Number of subjects: 120

Group type: COMPARATOR
Intervention: IV-PCA (morphine 2 mg/dose) with placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: DM patients
Number of subjects: 120
Study: 11692213

Group type: EXPERIMENTAL
Intervention: Histopathologic examination in IDC patients
Number of subjects: 72

Group type: COMPARATOR
Intervention: Histopathologic examination in comparison group (heart diseases of known causes)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Endocardial fibroelastosis in IDC patients
Number of subjects: 72

Group type: COMPARATOR
Intervention: Endocardial fibroelastosis in comparison group
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Distinct patterns of fibrosis
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Reactive fibrosis presence in IDC patients
Number of subjects: 72
Study: 9325588

Group type: EXPERIMENTAL
Intervention: Memory-based judgments
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: On-line judgments
Number of subjects: 2
Study: 7911306

Group type: EXPERIMENTAL
Intervention: d‐tubocurarine 50 micrograms/kg IV followed by vecuronium 60 micrograms/kg IV
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vecuronium 60 micrograms/kg IV without priming
Number of subjects: 40
Study: 2860819

Group type: EXPERIMENTAL
Intervention: Triazolam 0.25 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 29443372

Group type: EXPERIMENTAL
Intervention: Cangrelor
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Prasugrel 60 mg
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Clopidogrel 600 mg
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg
Number of subjects: 110
Study: 27863609

Group type: EXPERIMENTAL
Intervention: Pleasant natural sounds
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Both groups (pleasant natural sounds and control)
Number of subjects: 130
Study: 25039272

Group type: EXPERIMENTAL
Intervention: Combination therapy of sildenafil 100mg and vacuum erection device
Number of subjects: 66

Group type: COMPARATOR
Intervention: Vacuum erection device only
Number of subjects: 66
Study: 22120748

Group type: EXPERIMENTAL
Intervention: Dynamic visual noise (DVN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Static visual noise
Number of subjects: 0

Group type: COMPARATOR
Intervention: No interference control
Number of subjects: 0
Study: 20206891

Group type: EXPERIMENTAL
Intervention: Continuous intravenous (cIV) furosemide
Number of subjects: 56

Group type: COMPARATOR
Intervention: Intermittent intravenous (iIV) furosemide
Number of subjects: 56
Study: 18555933

Group type: EXPERIMENTAL
Intervention: Exenatide (5 microg BID for 1 week, then 10 microg BID for the next week)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 30
Study: 17635508

Group type: EXPERIMENTAL
Intervention: Active lotion containing triethyl citrate and ethyl linoleate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo control (vehicle)
Number of subjects: 40
Study: 15473116

Group type: EXPERIMENTAL
Intervention: Aerobic treadmill plus Bobath walking training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bobath walking training alone
Number of subjects: 50
Study: 10831815

Group type: EXPERIMENTAL
Intervention: Children with myelomeningocele
Number of subjects: 35

Group type: COMPARATOR
Intervention: Normal children (control group)
Number of subjects: 35
Study: 9353982

Group type: EXPERIMENTAL
Intervention: Movement analysis (MA) system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy people
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hemiparetic patients
Number of subjects: 0
Study: 1583673

Group type: EXPERIMENTAL
Intervention: Biofeedback
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Waiting list (Control)
Number of subjects: 20
Study: 2859075

Group type: EXPERIMENTAL
Intervention: Nine months' chemotherapy with rifampicin plus isoniazid supplemented by ethambutol for eight weeks
Number of subjects: 152

Group type: COMPARATOR
Intervention: Eighteen months' chemotherapy with rifampicin plus isoniazid supplemented by ethambutol for eight weeks
Number of subjects: 152
Study: 30187419

Group type: COMPARATOR
Intervention: American position
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: French position
Number of subjects: 18
Study: 27957668

Group type: EXPERIMENTAL
Intervention: Morning Meeting
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Academic Choice
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Baseline interaction quality
Number of subjects: 143
Study: 25534187

Group type: COMPARATOR
Intervention: CBD (16mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: THC (8mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: THC+CBD (8mg+16mg)
Number of subjects: 48
Study: 23658561

Group type: EXPERIMENTAL
Intervention: Aerobic dance combined with drug therapy (Hydrochlorothiazide + amiloride hydrochloride, and Amlodipine)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Drug therapy (Hydrochlorothiazide + amiloride hydrochloride, and Amlodipine)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Comparison of both groups post-intervention
Number of subjects: 63
Study: 21293851

Group type: EXPERIMENTAL
Intervention: Older fallers
Number of subjects: 3

Group type: COMPARATOR
Intervention: Age-matched non-fallers
Number of subjects: 3

Group type: COMPARATOR
Intervention: Younger adults
Number of subjects: 3
Study: 19842829

Group type: EXPERIMENTAL
Intervention: Condom availability in treatment programs
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Possession of condoms
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Future intention to use condoms
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Future intention to increase condom use
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Having a high-risk partner
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Low Condom Barriers Scale scores
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Being unmarried
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Ethnic minority status
Number of subjects: 324
Study: 16791111

Group type: EXPERIMENTAL
Intervention: Educational intervention using a standardized family member, including formal teaching of a communication framework and practice session.
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (no educational intervention).
Number of subjects: 106
Study: 16117969

Group type: EXPERIMENTAL
Intervention: Leishmanin skin test (LST)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo (merthiolate‐phosphate‐buffered saline)
Number of subjects: 59
Study: 10760830

Group type: EXPERIMENTAL
Intervention: 6 x CMF + RT
Number of subjects: 199

Group type: COMPARATOR
Intervention: 6 x CMF
Number of subjects: 199
Study: 9323505

Group type: EXPERIMENTAL
Intervention: 3 x 2 liter daily exchange
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: 4 daily exchanges
Number of subjects: 117

Group type: COMPARATOR
Intervention: Kt/V < 1.7
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Kt/V > or = 1.7
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 117
Study: 8405010

Group type: EXPERIMENTAL
Intervention: Ipratropium 80 mg q.i.d.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study: 3898970

Group type: EXPERIMENTAL
Intervention: POII cefamandole (2g)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 250